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Objective: This study aims to investigate the effect of 4 different dialysate temperatures on blood
pressure during hemodialysis for patients with hypertension.
Methods: Using a self-controlled method, the patients' body temperature was set as T. Accordingly, the
dialysate temperature was set as 37 C, Tþ0.5 C, T, and T0.5 C. The changes in blood pressure, heart
rate, mean arterial pressure and dialysis-induced adverse reactions at the 4 different dialysate temper-
atures were consistently monitored.
Results: Patients who received hemodialysis with 37 C and Tþ0.5 C dialysate demonstrated an un-
stable blood pressure and a higher incidence of adverse reactions. Patients who received hemodialysis
with T and T0.5 C dialysate showed a relatively stable blood pressure, heart rate, and mean arterial
pressure during dialysis. In particular, dialysate at T0.5 C resulted in the most stable blood pressure,
the fewest adverse reactions and the best self-assessed comfort scores (P < 0.01).
Conclusions: The dialysate temperature during hemodialysis for patients with hypertension should be
set to a temperature based on patients' preoperative body temperate T or 0.5 C below T. This practice is
suggested to enhance the stability of patients' blood pressure and heart rate during hemodialysis, reduce
complications and improve patients' tolerance of hemodialysis.
© 2016 Shanxi Medical Periodical Press. Publishing services by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In clinical work, the prevention and treatment of dialysis-
induced hypotension is typically timely and effective, but the
treatment of hypertension during dialysis is often ineffective, and
dialysis physicians even feel helpless in some intractable cases.
Hypertension in dialysis patients often manifests as ﬂushing,
headache, hot ﬂashes, vomiting, heavy sweating and other dis-
comforts. Conventionally, decreasing the conductivity and blood
ﬂow or the oral administration of antihypertensive drugs is used to
prevent and treat hypertension, but these interventions may not
result in a noticeable or stable response. Patients' blood pressures
often return to the original level or even higher soon after a short-
term reduction following treatment. The blood pressure eventually
falls back to normal levels by different post-dialysis time periods. In
addition, high blood pressure during dialysis causes fear, stress,
anxiety, and depression in patients and reduces their quality of life.al Periodical Press.
blishing services by Elsevier B.V. ThIt is also a safety risk during the dialysis session. In this study, we
used dialysates at 4 different temperatures in patients with hy-
pertension during dialysis to explore the best dialysate tempera-
ture to reduce blood pressure changes and the incidence of adverse
reactions during dialysis.2. Subjects and methods
2.1. Subjects
Twenty dialysis patients with hypertension in the hemodial-
ysis center at our hospital from January to December 2014 were
selected for this study. The inclusion criteria were as follows: (1)
adequate dialysis had been performed for more than 6 months;
(2) blood pressure gradually increased during the process of
dialysis, and the mean arterial pressure increased by 15 mmHg
(1 mmHg ¼ 0.133 kPa) or more compared with the level recorded
before dialysis.1 The exclusion criteria included the following: (1)
the hypertension occurred before dialysis, but the blood pressure
gradually decreased to normal during the process of dialysis; (2)
the blood pressure during dialysis was dangerously high, with theis is an open access article under the CC BY-NC-ND license (http://creativecommons.
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patient had recently experienced a fever or had a history of
infection, acute cardiovascular or cerebrovascular disease, or hy-
perthyroidism; and (4) the patient refused to cooperate. All of the
enrolled patients signed the written informed consent. There
were 10 males and 10 females aged between 42 and 67 years
(52.3 ± 6.7) years with a dialysis duration of 8 months to 65
months (18.1 ± 16.5) months and an average blood pressure of
(155.8 ± 11.9)/(90.9 ± 11.2) mmHg. Their underlying renal diseases
included 6 cases of chronic glomerulonephritis, 8 cases of diabetic




An F6HPS polysulfone dialyzer was used for the dialysis (4 h per
treatment, three times per week for each patient). The blood ﬂow
ratewas set at 200e250mL/min, and the dialysate ﬂow ratewas set
at 500 mL/min. The bicarbonate dialysate used comprised various
concentrations of ions: HCO3- at 32 mmol/L, Naþ at 138 mmol/L, Kþ
at 2.0 mmol/L, Ca2þ at 1.25 mmol/L, Mg2þ at 0.5 mmol/L, Cl- at
108mmol/L and CH3COO- at 3.0mmol/L. The electrical conductivity
was set to 138 ms/cm. Conventional heparin or low-molecular-
weight heparin was used for anticoagulation. Before the study
was started, all of the patients had their body weight under control,
and their average dry body weight was 52.2 ± 13.4 kg. The ultra-
ﬁltration volume was 2.3 ± 1.2 kg per dialysis treatment. The
antihypertensive and dialysis treatment options were kept at the
same for all patients. Patients' oral temperature was measured for
5 min with a mercury thermometer immediately before starting
dialysis.
Previous studies have shown that an elevated dialysate tem-
perature can increase the blood temperature, thus decreasing blood
pressure.2 In contrast, our previous research results also indicated
that extremely high dialysate temperatures could cause a higher
incidence of headaches, hot ﬂashes, heart palpitations, chest
tightness, nausea, vomiting and other adverse reactions, while
extremely low dialysate temperatures could increase blood pres-
sure in dialysis patients.3 Therefore, in this study, we excluded
interference from extremely high and low temperatures. We
measured patients' pre-dialysis body temperature, denoted as T,
and carried out our experiment on patients using dialysate at four
different temperatures: (1) 37 C, as the default standard dialysate
temperature parameter of the dialysis machine; (2) Tþ0.5 C, 0.5 C
higher than the measured body temperature (T), on average
37.2 ± 0.7 C; (3) T, the measured body temperature, on average
36.8 ± 0.4 C; and (4) T0.5 C, 0.5 C lower than the measured
body temperature, on average 36.1 ± 0.7 C. Each patient was dia-
lyzed for 4 weeks at each temperature, 3 times per week. The
ambient temperature in the hemodialysis center was 22Ce24 C,
and the humidity was maintained at 50%e60%.
2.2.2. Measurement criteria
(1) The hourly changes in blood pressure, heart rate and mean
arterial pressure during dialysis were monitored. (2) The frequency
of adverse reactions, such as headaches, hot ﬂashes, palpitations
and dyspnea, nausea and vomiting, sweating, and chills was
observed and recorded for the dialysis patients. (3) The number of
early dialysis session terminations was recorded. (4) The frequency
of administering antihypertensive drug was recorded. During
dialysis, if the systolic blood pressurewas higher than 180mmHg or
if the diastolic blood pressure was higher than100 mmHg, patients
were given antihypertensive drugs. (5) Patient comfort scores were
assessed using a visual analog scale over a 10-point range4 andwere given by the dialysis patients according to their own subjec-
tive feeling. On this scale, 0e2 points represents comfortable, 3e4
represents mild discomfort, 5e6 represents moderate discomfort,
7e8 represents discomfort and 9e10 represents extreme
discomfort.
2.2.3. Statistical analysis
SPSS17.0 software was used for statistical analysis. Measure-
ments were represented as the mean ± standard deviation (x

± s).
Categorical data were expressed in percentages. An F test was used
for intergroup comparison. The c2 test was applied to compare
percentage data. The difference was considered statistically sig-
niﬁcant when P < 0.05.
3. Results
3.1. Changes in blood pressure, heart rate and mean arterial
pressure in patients at 4 different dialysate temperatures
Application of 37 C and Tþ0.5 C dialysate resulted in signiﬁ-
cant changes in blood pressure, heart rate and mean arterial pres-
sure (P < 0.05) in dialysis patients. However, no signiﬁcant changes
in the patients' blood pressure, heart rate, or mean arterial pressure
(P > 0.05) were observed in dialysis processes at T and T0.5. In
particular, T0.5 C resulted in the most stable measurement
outcomes as shown in Table 1 and Table 2.
3.2. Comparison of adverse reactions and patient's comfort score
among dialysis patients at 4 different dialysate temperatures
Patients treated with dialysate at 37 C and Tþ0.5 C showed
relatively higher incidence rates of adverse reactions and the need
for the administration of antihypertensive drugs. In contrast, pa-
tients treated with dialysate at T and T0.5 C showed lower
incidence rates of adverse reactions and the need for the admin-
istration of antihypertensive drugs. In particular, patients receiving
dialysate at T0.5 C showed the best comfort rating outcomes
(lowest scores, P < 0.01). No statistically signiﬁcant difference
(P > 0.05) was observed for the rate of early termination of dialysis
between groups as shown in Table 3.
4. Discussions
4.1. Incidence and risk of hypertension in hemodialysis patients
Nearly 80% of maintenance hemodialysis patients have hyper-
tension.5 The majority of hypertensive patients in hemodialysis
receive antihypertensive drug treatment, but only 30% achieve
good control of their blood pressure. Some patients in dialysis show
an increase rather than a decrease in their blood pressure.6,7 Severe
hypertension and the use of anticoagulants are risk factors for
cardiovascular and cerebrovascular diseases in patients, potentially
causing serious impacts on quality of life and patient safety.
Therefore, it is important to prevent and control hypertension
during dialysis.
4.2. Effect of dialysate temperature on blood pressure in
hemodialysis patients
Human blood pressure regulatory pathways involve sympa-
thetic regulation, the renin-angiotensin-aldosterone system, regu-
lation of cardiac output and peripheral vascular tension, etc.8
Therefore, adjustment of the dialysate temperature as a means to
regulate patients' body temperature and blood pressure and to
balance patients' body energy was explored in this study.9 Some
Table 1



























F P F P
37 240 151.4 ± 12.1 85.2 ± 8.4 165.1 ± 15.2 97.3 ± 9.8 159.1 ± 17.3 98.3 ± 10.8 152.6 ± 20.2 95.3 ± 8.4 3.27 <0.05 3.51 <0.05
Tþ0.5 240 150.9 ± 15.2 87.62 ± 8.5 162.8 ± 21.7 99.4 ± 9.7 156.4 ± 25.9 92.3 ± 11.6 154.2 ± 23.2 91.0 ± 10.0 2.95 <0.05 2.82 <0.05
T 240 150.4 ± 14.9 90.0 ± 9.2 147.8 ± 13.7 88.1 ± 7.5 148.1 ± 14.2 88.9 ± 10.8 151.3 ± 16.6 89.3 ± 11.0 1.93 >0.05 1.61 >0.05
T-0.5 240 149.93 ± 16.5 87.0 ± 8.6 152.5 ± 17.8 89.1 ± 9.6 148.1 ± 13.7 89.0 ± 9.5 145.0 ± 26.0 86.6 ± 15.3 1.65 >0.05 1.25 >0.05
Table 2
























F P F P
37 240 108.26 ± 10.34 76 ± 5 119.68 ± 12.27 89 ± 6 109.75 ± 13.78 86 ± 7 110.19 ± 17.44 86 ± 6 5.97 <0.01 2.94 <0.05
Tþ0.5 240 107.78 ± 9.94 78 ± 7 110.25 ± 10.59 92 ± 8 108.70 ± 14.86 87 ± 7 106.10 ± 17.54 86 ± 6 4.68 <0.01 3.27 <0.05
T 240 110.12 ± 9.24 72 ± 6 108.03 ± 7.83 78 ± 7 108.62 ± 10.45 84 ± 7 110.03 ± 11.02 80 ± 8 1.42 >0.05 1.04 >0.05
T-0.5 240 108.73 ± 8.87 78 ± 8 110.57 ± 11.71 72 ± 7 108.70 ± 9.41 70 ± 6 112.11 ± 12.30 72 ± 6 1.16 >0.05 0.97 >0.05
Note: The unit for mean arterial pressure was mmHg, and the unit for heart rate was beats/min.
Table 3
Comparison of adverse reactions in dialysis patients at 4 different temperatures. (n ¼ 20).




Cases of administration of
antihypertensive drugs (%)
Comfort score
37 42 (17.5) 0 (0.0) 13 (5.4) 2.01 ± 0.43
Tþ0.5 100 (41.6) 2 (0.8) 16 (6.7) 2.57 ± 0.45
T 0 (0.0) 0 (0.0) 0 (0.0) 0.69 ± 0.16
T-0.5 6 (2.5) 0 (0.0) 0 (0.0) 0.54 ± 0.15
c2/F 10.54 1.05 2.97 13.7
P <0.01 >0.05 <0.05 <0.01
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differences is correlated with the pre-dialysis body temperature.10
Some studies have also conﬁrmed that a high dialysate tempera-
ture can increase blood temperature, decrease blood pressure and
cause fever, tachycardia, nausea, vomiting and other symptoms.2 In
this study, the dialysate temperatures were selected based on the
pre-dialysis measured body temperature, T. At the standard dialy-
sate temperature 37 C and Tþ0.5 C, the majority of patients
showed an increase rather than a decrease in blood pressure. Some
patients experienced headache, irritability, heavy sweating, nausea,
vomiting and other symptoms. In addition, 2 patients complained
of severe headache and dizziness and requested early termination
of the dialysis session. For patients with dialysates at T and
T0.5 C, and especially for patients with dialysate at T, their heart
rates were stable, and their blood pressure (i.e., their mean arterial
pressure) showed only a slight increase, which was not statistically
signiﬁcant (P > 0.05). In addition, adverse reactions were less
common in these patients, and only 2 patients undergoing dialysis
with dialysate at these temperatures showed minor chills but were
able to ﬁnish the entire course of dialysis. In this study, patients
undergoing dialysis with dialysate at 37 C and Tþ0.5 C did not
show any decrease in blood pressure with the increase in dialysate
temperature. Patients undergoing dialysis with dialysate at T and
T0.5 C exhibited relatively stable blood pressures, which may be
attributable to the controlled average heart rate during hemodial-
ysis.11 Patients undergoing dialysis with dialysates at Tand T0.5 C
could avoid the restlessness and heavy sweating caused by higher
dialysate temperatures and the inaccurate ultraﬁltration volumesgenerated by a subsequent early termination of dialysis. This
practice increased patient tolerance during dialysis treatment. At
the same time, patients undergoing dialysis with dialysates at T and
T0.5 C experienced a smooth process without headache or other
adverse reactions, which may be related to the avoidance of
increased sympathetic activity due to increased body temperature,
which is in agreement with the study by Zhang et al.12
4.3. The signiﬁcance of a reasonable setting for dialysate
temperature on control of blood pressure during hemodialysis
During hemodialysis, a too high, too low or highly ﬂuctuant
blood pressure will affect the blood supply to vital organs and can
even endanger patients' lives. Therefore, maintaining a stable blood
pressure and heart rate during the process of dialysis has a very
high clinical importance. In this study on patients with hyperten-
sion, an appropriate reduction in the dialysate temperature based
on the measured pre-dialysis body temperature (T0.5 C) not only
stabilized blood pressures but effectively reduced the occurrence of
complications during dialysis and improved dialysis tolerance and
the accuracy of ultraﬁltration, achieving better dialysis outcomes.
This practice is worth promoting in clinical application. The best
reasonable selection of dialysate temperature should be adjusted
according to individual differences in patients.
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